)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Evofem Biosciences
Evofem Biosciences (EVFM) investor relations material
Evofem Biosciences Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary11 Mar, 2026
Executive summary
Achieved record net sales of $20.2 million in 2025, marking the fifth consecutive year of net sales growth, primarily driven by PHEXX and SOLOSEC sales.
Income from operations rose to $3.4 million in 2025, compared to a loss of $7.7 million in 2024.
Net income attributable to common stockholders was $0.3 million in 2025, versus a net loss of $9.0 million in 2024.
Financial highlights
Net sales increased 4% year-over-year to $20.2 million in 2025, up from $19.4 million in 2024.
Fourth quarter 2025 net sales were $9.6 million, a 35% increase from $7.1 million in Q4 2024.
Total operating expenses dropped 38% to $16.8 million in 2025, driven by reductions in R&D and G&A expenses.
Operating income for Q4 2025 was $3.3 million, compared to a $1.0 million loss in Q4 2024.
Q4 2025 net income was $2.8 million, versus a net loss of $3.0 million in Q4 2024.
Outlook and guidance
Initiatives underway to lower manufacturing costs for both PHEXX and SOLOSEC, targeting 55-60% reductions.
Anticipated regulatory approval for PHEXX in the UAE following favorable pricing certificates.
EDE review of SOLOSEC application in the UAE is ongoing.
Recurring vs non-recurring expense reductions?
SOLOSEC Phase 4 trial impact on market share?
Plan to address going concern risk?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Evofem Biosciences
- Liquidity crisis, debt defaults, and rebranding persist despite cost cuts and new growth initiatives.EVFM
Q3 202413 Jan 2026 - Resolving a senior creditor issue is crucial for advancing global growth in women's health.EVFMStatus Update26 Dec 2025
- Merger approval with Aditxt expected, advancing women's health innovation and resources.EVFMProxy Filing1 Dec 2025
- Special Meeting moved to October 20, 2025; dissenters' rights clarified and available.EVFMProxy Filing1 Dec 2025
- Shareholders to vote on Evofem's merger with Aditxt, offering cash and preferred stock exchange.EVFMProxy Filing1 Dec 2025
- Evofem shareholders to receive cash and Aditxt preferred stock in merger pending key approvals.EVFMProxy Filing1 Dec 2025
- Shareholders to vote on merger making Evofem a subsidiary of Aditxt, with cash and stock consideration.EVFMProxy Filing1 Dec 2025
- Shareholders will vote on a merger for cash and preferred stock, with key conditions and risk factors disclosed.EVFMProxy Filing1 Dec 2025
- Proxy seeks approval for director elections, equity plan, reverse split, and auditor ratification.EVFMProxy Filing1 Dec 2025
Next Evofem Biosciences earnings date
Q1 202614 May, 2026
Evofem Biosciences
Next Evofem Biosciences earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Evofem Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage